Browsing: Other

Did two recent studies find that ipsilateral breast tumor recurrence risk was clearly lower when >2 mm margins were taken…

A randomized trial demonstrated adding to usual counseling and pharmacotherapy up to $600 financial incentives for biochemically confirmed 6-month smoking…

Siemens Healthineers/Varian announced a new LINAC platform called Accela. It appears to be a C-arm linac platform, and the big…

The Headline: Protons are no better than photons in treating hepatocellular carcinoma.The Study: Does proton dosimetry actually translate to better…

The Headline: Low dose radiation may do more than just reduce symptoms of osteoarthritis. The Study: Low dose RT is…

This prospective, single arm trial evaluated ultra low dose palliative radiation for myeloma bone lesions. It included 63 patients with…

A meta-meta-analysis suggests carboplatin can replace cisplatin when particularly concerns for nephrotoxicity or ototoxicity predominate for most cancer sites other…

Top Line: Yesterday the FDA’s Molecular and Clinical Genetics Devices Panel advisory board voted in favor of approval of GRAIL’s…

Top Line: Can today’s multicancer early-detection (MCED) testing solve more problems than it creates?The Study: Everyone–particularly investors–is buzzing about the…

In a recent study, what proportion of breast cancer patients had coronary artery calcifications? Are ctDNA levels prognostic of outcomes…